Trial Information
A Phase I Dose Escalation and Expanded Cohort Study Of Pf-06821497 In The Treatment Of Adult Patients With Relapsed/Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC) And Follicular Lymphoma (FL)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
